← Back to work
Works cited by this work
172 works
Work: Targeted Protein Degradation in Cancer: PROTACs, New Targets, and Clinical Mechanisms
Targeted degradation of ⍺-synuclein aggregates in Parkinson’s disease using the AUTOTAC technology
Jihoon Lee, Ki Woon Sung, Eun-Jin Bae +12
Article20232 citationsABISecond-Generation AUTACs for Targeted Autophagic Degradation
Daiki Takahashi, Taiichi Ora, Shigekazu Sasaki +11
Article20232 citationsABIRecent advances in dual PROTACs degrader strategies for disease treatment
Jianyu Liu, Yanzhuo Liu, Jiao Tang +5
Review article20242 citationsABIA covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy
Youmei Xiao, Zhuoying He, Wanqiong Li +13
Article20252 citationsABILysosome-Targeting Chimera Using Mannose-6-Phosphate Glycans Derived from Glyco-Engineered Yeast
Seobin Kim, Jiyeon Kang, D.R. An +2
Article20252 citationsABIPSMD12 promotes hepatocellular carcinoma progression by stabilizing CDK1
Xingyu Peng, Zitao Liu, Chen Luo +6
Article20252 citationsABIMethods to accelerate PROTAC drug discovery
Jeyan Osman, Philip E. Thompson, Manuela Jörg +1
Review article20252 citationsABIRevolutionizing Drug Discovery: A Systematic Review of AI and Machine Learning Application
Ismatul Jannat Chowdhury, Md. Shorif Hossan, Mohammed Ziauddin Khan +4
Review article20252 citationsABI